155 related articles for article (PubMed ID: 34437731)
1. Hyperactivation of MEK/ERK pathway by Ca
Najar MA; Aravind A; Dagamajalu S; Sidransky D; Ashktorab H; Smoot DT; Gowda H; Prasad TSK; Modi PK; Chatterjee A
Mol Carcinog; 2021 Nov; 60(11):769-783. PubMed ID: 34437731
[TBL] [Abstract][Full Text] [Related]
2. Using the fluorescent properties of STO-609 as a tool to assist structure-function analyses of recombinant CaMKK2.
Gerner L; Munack S; Temmerman K; Lawrence-Dörner AM; Besir H; Wilmanns M; Jensen JK; Thiede B; Mills IG; Morth JP
Biochem Biophys Res Commun; 2016 Jul; 476(2):102-7. PubMed ID: 27178209
[TBL] [Abstract][Full Text] [Related]
3. Akt activation by Ca
Gocher AM; Azabdaftari G; Euscher LM; Dai S; Karacosta LG; Franke TF; Edelman AM
J Biol Chem; 2017 Aug; 292(34):14188-14204. PubMed ID: 28634229
[TBL] [Abstract][Full Text] [Related]
4. Molecular Profiling Associated with Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2)-Mediated Carcinogenesis in Gastric Cancer.
Najar MA; Modi PK; Ramesh P; Sidransky D; Gowda H; Prasad TSK; Chatterjee A
J Proteome Res; 2021 May; 20(5):2687-2703. PubMed ID: 33844560
[TBL] [Abstract][Full Text] [Related]
5. Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma.
Subbannayya Y; Syed N; Barbhuiya MA; Raja R; Marimuthu A; Sahasrabuddhe N; Pinto SM; Manda SS; Renuse S; Manju HC; Zameer MA; Sharma J; Brait M; Srikumar K; Roa JC; Vijaya Kumar M; Kumar KV; Prasad TS; Ramaswamy G; Kumar RV; Pandey A; Gowda H; Chatterjee A
Cancer Biol Ther; 2015; 16(2):336-45. PubMed ID: 25756516
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Ca²⁺/calmodulin-dependent protein kinase kinase 2 stimulates osteoblast formation and inhibits osteoclast differentiation.
Cary RL; Waddell S; Racioppi L; Long F; Novack DV; Voor MJ; Sankar U
J Bone Miner Res; 2013 Jul; 28(7):1599-610. PubMed ID: 23408651
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD.
York B; Li F; Lin F; Marcelo KL; Mao J; Dean A; Gonzales N; Gooden D; Maity S; Coarfa C; Putluri N; Means AR
Sci Rep; 2017 Sep; 7(1):11793. PubMed ID: 28924233
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CaMKK2 reverses age-associated decline in bone mass.
Pritchard ZJ; Cary RL; Yang C; Novack DV; Voor MJ; Sankar U
Bone; 2015 Jun; 75():120-7. PubMed ID: 25724145
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine Phosphorylation Profiling Revealed the Signaling Network Characteristics of CAMKK2 in Gastric Adenocarcinoma.
Najar MA; Arefian M; Sidransky D; Gowda H; Prasad TSK; Modi PK; Chatterjee A
Front Genet; 2022; 13():854764. PubMed ID: 35646067
[TBL] [Abstract][Full Text] [Related]
10. Activation of the aryl hydrocarbon receptor by the calcium/calmodulin-dependent protein kinase kinase inhibitor 7-oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic acid (STO-609).
Monteiro P; Gilot D; Langouet S; Fardel O
Drug Metab Dispos; 2008 Dec; 36(12):2556-63. PubMed ID: 18755850
[TBL] [Abstract][Full Text] [Related]
11. Role of Ca(2+)/calmodulin-dependent protein kinase kinase in adrenal aldosterone production.
Nanba K; Chen A; Nishimoto K; Rainey WE
Endocrinology; 2015 May; 156(5):1750-6. PubMed ID: 25679868
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
13. CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis.
Penfold L; Woods A; Muckett P; Nikitin AY; Kent TR; Zhang S; Graham R; Pollard A; Carling D
Cancer Res; 2018 Dec; 78(24):6747-6761. PubMed ID: 30242113
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic roles of Ca
Ha TT; Burwell ST; Goodwin ML; Noeker JA; Heggland SJ
Toxicol Lett; 2016 Oct; 260():18-27. PubMed ID: 27558804
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CaMKK2 Enhances Fracture Healing by Stimulating Indian Hedgehog Signaling and Accelerating Endochondral Ossification.
Williams JN; Kambrath AV; Patel RB; Kang KS; Mével E; Li Y; Cheng YH; Pucylowski AJ; Hassert MA; Voor MJ; Kacena MA; Thompson WR; Warden SJ; Burr DB; Allen MR; Robling AG; Sankar U
J Bone Miner Res; 2018 May; 33(5):930-944. PubMed ID: 29314250
[TBL] [Abstract][Full Text] [Related]
16. In Depth Analysis of Kinase Cross Screening Data to Identify CAMKK2 Inhibitory Scaffolds.
O'Byrne SN; Scott JW; Pilotte JR; Santiago ADS; Langendorf CG; Oakhill JS; Eduful BJ; Couñago RM; Wells CI; Zuercher WJ; Willson TM; Drewry DH
Molecules; 2020 Jan; 25(2):. PubMed ID: 31941153
[TBL] [Abstract][Full Text] [Related]
17. CaMKK2 Promotes the Progression of Ovarian Carcinoma through the PI3K/PDK1/Akt Axis.
Chen Z; Sun X; Xia Z; Wang J; Guo N; Zhang Y
Comput Math Methods Med; 2022; 2022():7187940. PubMed ID: 35309839
[TBL] [Abstract][Full Text] [Related]
18. miR-302b regulates cell cycles by targeting CDK2 via ERK signaling pathway in gastric cancer.
Liu FY; Wang LP; Wang Q; Han P; Zhuang WP; Li MJ; Yuan H
Cancer Med; 2016 Sep; 5(9):2302-13. PubMed ID: 27465546
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of mixed lineage kinase MLK3 by cyclin-dependent kinases CDK1 and CDK2 controls ovarian cancer cell division.
Cedeno-Rosario L; Honda D; Sunderland AM; Lewandowski MD; Taylor WR; Chadee DN
J Biol Chem; 2022 Aug; 298(8):102263. PubMed ID: 35843311
[TBL] [Abstract][Full Text] [Related]
20. CaMKK2 kinase domain interacts with the autoinhibitory region through the N-terminal lobe including the RP insert.
Kylarova S; Psenakova K; Herman P; Obsilova V; Obsil T
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2304-2313. PubMed ID: 30053538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
